88 related articles for article (PubMed ID: 26874397)
1. The molecular structure of thio-ether fatty acids influences PPAR-dependent regulation of lipid metabolism.
Lund J; Stensrud C; Rajender ; Bohov P; Thoresen GH; Berge RK; Wright M; Kamal A; Rustan AC; Miller AD; Skorve J
Bioorg Med Chem; 2016 Mar; 24(6):1191-203. PubMed ID: 26874397
[TBL] [Abstract][Full Text] [Related]
2. Sulfur-substituted and alpha-methylated fatty acids as peroxisome proliferator-activated receptor activators.
Larsen LN; Granlund L; Holmeide AK; Skattebøl L; Nebb HI; Bremer J
Lipids; 2005 Jan; 40(1):49-57. PubMed ID: 15825830
[TBL] [Abstract][Full Text] [Related]
3. Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation.
Løvås K; Røst TH; Skorve J; Ulvik RJ; Gudbrandsen OA; Bohov P; Wensaas AJ; Rustan AC; Berge RK; Husebye ES
Diabetes Obes Metab; 2009 Apr; 11(4):304-14. PubMed ID: 19267708
[TBL] [Abstract][Full Text] [Related]
4. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
[TBL] [Abstract][Full Text] [Related]
5. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
6. Novel phospholipid analogues of pan-PPAR activator tetradecylthioacetic acid are more PPAR alpha selective.
Bhurruth-Alcor Y; Rost TH; Jorgensen MR; Rajender ; Müller M; Skorve J; Berge RK; Miller AD
Bioorg Med Chem Lett; 2010 Feb; 20(3):1252-5. PubMed ID: 20036122
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome and the hepatic fatty acid drainage hypothesis.
Berge RK; Tronstad KJ; Berge K; Rost TH; Wergedahl H; Gudbrandsen OA; Skorve J
Biochimie; 2005 Jan; 87(1):15-20. PubMed ID: 15733731
[TBL] [Abstract][Full Text] [Related]
8. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
[TBL] [Abstract][Full Text] [Related]
9. ATGL-mediated triglyceride turnover and the regulation of mitochondrial capacity in skeletal muscle.
Meex RC; Hoy AJ; Mason RM; Martin SD; McGee SL; Bruce CR; Watt MJ
Am J Physiol Endocrinol Metab; 2015 Jun; 308(11):E960-70. PubMed ID: 25852007
[TBL] [Abstract][Full Text] [Related]
10. Metabolic switching of human skeletal muscle cells in vitro.
Thoresen GH; Hessvik NP; Bakke SS; Aas V; Rustan AC
Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):227-34. PubMed ID: 21549583
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
12. Increased glucose utilization and decreased fatty acid metabolism in myotubes from Glmp(gt/gt) mice.
Kong XY; Feng YZ; Eftestøl E; Kase ET; Haugum H; Eskild W; Rustan AC; Thoresen GH
Arch Physiol Biochem; 2016; 122(1):36-45. PubMed ID: 26707125
[TBL] [Abstract][Full Text] [Related]
13. Effects of 3-thia fatty acids on expression of some lipid related genes in Atlantic salmon (Salmo salar L.).
Kleveland EJ; Ruyter B; Vegusdal A; Sundvold H; Berge RK; Gjøen T
Comp Biochem Physiol B Biochem Mol Biol; 2006 Oct; 145(2):239-48. PubMed ID: 16971150
[TBL] [Abstract][Full Text] [Related]
14. Effect of nutritional vitamin A deficiency on lipid metabolism in the rat heart: Its relation to PPAR gene expression.
Vega VA; Anzulovich AC; Varas SM; Bonomi MR; Giménez MS; Oliveros LB
Nutrition; 2009; 25(7-8):828-38. PubMed ID: 19342198
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and analysis of novel glycerolipids for the treatment of metabolic syndrome.
Jorgensen MR; Bhurruth-Alcor Y; Røst T; Bohov P; Müller M; Guisado C; Kostarelos K; Dyrøy E; Berge RK; Miller AD; Skorve J
J Med Chem; 2009 Feb; 52(4):1172-9. PubMed ID: 19175322
[TBL] [Abstract][Full Text] [Related]
16. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
[TBL] [Abstract][Full Text] [Related]
17. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Madin-Darby bovine kidney cell line for peroxisome proliferator-activated receptors: temporal response and sensitivity to fatty acids.
Bionaz M; Baumrucker CR; Shirk E; Vanden Heuvel JP; Block E; Varga GA
J Dairy Sci; 2008 Jul; 91(7):2808-13. PubMed ID: 18565938
[TBL] [Abstract][Full Text] [Related]
19. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
Fuster G; Busquets S; Ametller E; Olivan M; Almendro V; de Oliveira CC; Figueras M; López-Soriano FJ; Argilés JM
Cancer Res; 2007 Jul; 67(13):6512-9. PubMed ID: 17616713
[TBL] [Abstract][Full Text] [Related]
20. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.
Mansour M
Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
